For a few moments that evening, the spotlight focused on Ms. Stavros of Pickering, Ont. She was the first in the country who ...

Crosby’s and Reid Petroleum successfully concluded their 2025 campaign partnership with the Cystic Fibrosis Foundation, ...

Elexacaftor-tezacaftor-ivacaftor (ETI) may improve bronchial dilatations in adolescents with cystic fibrosis (CF).

Among adults and adolescents with cystic fibrosis starting triple therapy for the first time, inflammatory markers fell and ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Vertex Pharmaceuticals has underperformed the broader Nasdaq index over the past year. However, Wall Street analysts remain ...

In 1969, Rod Macleod was training to become a child psychiatrist at Montreal Children’s Hospital. It was a busy and exciting ...

At 50 years old, my health began to deteriorate in ways no one could explain. For nearly two decades, I searched for answers. It wasn’t until I was 69 that I finally learned the truth: I have cystic ...

ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA ...

Caleigh has struggled most of her life with a difficult lung disease, but she never lets it get the best of her.

For those who don’t benefit from modulators, the fight against CF can feel isolating and uncertain. Five members of our community share how they’ve transformed their personal struggles into purpose — ...

Pediatric patients with cystic fibrosis starting triple combination therapy had larger relative improvements in 129Xenon MRI ...